首页 › 癌症（所有类型） › 俄亥俄州 › Columbus
Columbus OH 癌症（所有类型）临床试验
38项针对 癌症（所有类型）的研究正在 Columbus及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
招募中3 期
- The Ohio State University, Columbus
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
招募中1/2 期
- GSK Investigational Site, Columbus
Met Non Small Cell Cancer Registry (MOMENT)
招募中观察性研究
- The Ohio State University Wexner Medical Center, Columbus
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
招募中观察性研究
- Ohio State University, Columbus
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
招募中2 期
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0008), Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
招募中观察性研究
- The Ohio State University Comprehensive Cancer Center, Columbus
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
招募中3 期
- Quetzal Site 8, Columbus
Pan Tumor Rollover Study
招募中2 期
- The Ohio University, Columbus
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
招募中2/3 期
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Collection of Tissue Samples for Cancer Research
招募中观察性研究
- Ohio State University, Columbus
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
招募中2 期
- The Ohio State University, Department of Psychiatry, Columbus
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
招募中观察性研究
- Ohio State University, Columbus
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- The Ohio State University Comprehensive Cancer Center, Columbus
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
招募中2 期
- Nationwide Children's Hosp, Columbus
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- 以及另外 8 项
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
招募中2 期
- Nationwide Children's Hospital, Columbus
The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
招募中
- Nationwide Children's Hospital, Columbus
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
招募中1/2 期
- The Ohio State University /ID# 271336, Columbus
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
招募中1 期
- The Ohio State University Comprehensive Cancer Center, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- Stefanie Spielman Comprehensive Breast Center, Columbus
Childhood Cancer Survivor Study
招募中观察性研究欢迎健康志愿者
- Nationwide Children's Hospital, Columbus
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
招募中观察性研究
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
招募中1/2 期
- The Ohio State University Comprehensive Cancer Center, Columbus
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
招募中2 期
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
招募中1/2 期
- The Ohio State University Wexner Medical Center, Columbus
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
招募中1/2 期
- Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
招募中2 期
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
招募中观察性研究
- Ohio State University Wexner Medical Center, Columbus
Re-Engaging AYA Survivors in Cancer-Related Healthcare
招募中
- Nationwide Children's Hospital, Columbus
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
招募中2 期
- The Ohio State University /ID# 230439, Columbus
GEMINI-NSCLC: NSCLC Biomarker Study
招募中观察性研究
- Ohio State University, Columbus
- OhioHealth Reseach Institute, Columbus
Preparing for Life and Academics for Young Childhood Cancer Survivors
招募中
- Nationwide Children's Hospital, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
招募中1/2 期
- The Ohio State University, Columbus
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
招募中观察性研究
- Ohio State University, Columbus
- OhioHealth Research Institute, Columbus
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- Ohio State University Comprehensive Cancer Center, Columbus
其他城市的 癌症（所有类型）试验
- Houston, TX121 项研究
- New York City, NY109 项研究
- Boston, MA85 项研究
- Los Angeles, CA74 项研究
- Nashville, TN65 项研究
- Philadelphia, PA59 项研究
- Washington, DC58 项研究
- Durham, NC58 项研究
- Chicago, IL51 项研究
- Atlanta, GA49 项研究
- Seattle, WA49 项研究
- Arlington, VA48 项研究
Columbus的其他研究
- 非小细胞肺癌57 项研究
- 乳腺癌40 项研究
- 卵巢癌39 项研究
- 肺癌37 项研究
- 急性髓系白血病35 项研究
- 慢性淋巴细胞白血病28 项研究
- 转移性癌症27 项研究
- 子宫内膜癌25 项研究
- 前列腺癌24 项研究
- 多发性骨髓瘤24 项研究
- 结直肠癌24 项研究
- 黑色素瘤21 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。